The relationship between hypertension and angina pectoris; physiological & Biochemical study of patients Samarra city

Main Article Content

Mostafa A. Abdulrahman

Abstract

This study was conducted for the period from 09/2013 to 02/2014 at Samarra General Hospital labs with patients admitted in the corridors of recovery for the patients with angina pectoris; ratio to the disease of hypertension is the pressure measurement during a hospital, (50-65) age nonsmoker. Reveiew as results  showed high significant in hypertension for people in hypertension , angina pectoris compared with the control group in,as well as high significant in lipid profile (cholesterol, triglycerides). the high increase in angina pectoris group compared hypertension with group compared with control group at the level( P <0.05 ). As for the lipoproteins, a decrease significant in the concentration of HDL-C was the largest decrease  in angina pectoris when compared with hypertension  group and the control group. at the same time high LDL-C concentration in a angina pectoris when compared with the control group, as to the biochemical variety results for increase significant in the concentration of blood sugar in the two study groups .show results high in angina pectoris when compared with hypertension group and the control group ,uric acid show results high in angina pectoris when compared with hypertension group and the control group.

Article Details

How to Cite
Mostafa A. Abdulrahman. (2023). The relationship between hypertension and angina pectoris; physiological & Biochemical study of patients Samarra city. Tikrit Journal of Pure Science, 20(1), 1–5. https://doi.org/10.25130/tjps.v20i1.1127
Section
Articles

References

2-Bønaa K.H and Thelle, D.S.(2014). Association between blood pressure and serum lipids in a population. The Tromsø Study. Circulation . 83, . 4:1305-14.

3-Giles, T.D.; Berk, B.C.; Black, H.R.; Cohn, J.N.; Kosti,s J.B., Izzo, J.L., and Weber, M.A.(2005). Expanding the Definition and Classification of Hypertension. Journal of Clinical Hypertension, 7(9): 505-512.

4- Chalmers, J.; Omae, T.,and Gyarfas, I.( 1999). Guidelines Sub-Committee, World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Journal of Hypertension, 17(2): 151-183.

5-De Ramirez S.S.; Enquobahrie D.A.; Nyadzi G.; Mjungu D., and Magombo F . (2010) Prevalence and correlates of hypertension: a cross-sectional study among rural populations in sub-Saharan Africa. J. Hum. Hypertens 2: 786-795.

6-Wiener C.; Fauci A.S.; and Braunwald E.(2008). Harrison's principles of internal medicine. 17PthP ed. New York: McGraw-Hill.

7-Julian D.G.; J. Campbell cowan ,and James M. Mclenachan (2000). Cardriology. Meain ed, WB. Saunders company , Ltd . 23-40, 7 , 92-93.

8-Boon N.A., Fox K.A.A., Bloomfield P and Bradburg A.(2000). Cardiovascular disease. Davidson’s principles and practice of medicine.19PthP ed. Churchill Livingstone: Edinburgh:357-61,420-22.

10-Whitworth, J.A., Kaplan, Nm., Mendis, S., and Poulter, N.(2003). World Health Organizatio ( WHO) / International Society of Hypertension (ISH) Statement on management of hypertension. Journal of Hypertension, 21(11): 1983-1992.

11-Franklin, S.S., Larson, M.G., Kahn, S.A., Wong ,N.D., Leip, E.P., Kannel, W.B. and, Levy, D.( 2001). Does the relation of Blood Pressure to Coronary Heart Disease risk change with ageing? The Framingham Heart Study. Circulation, 103: 1245-124.

12-Moncia, G., Guy, D.B., Anna, D., Renata, C., Robert, F., Giuseppe, G., Guido, G., Anthony, M.H., Sverre, E.K., Stephane, L., Krzysztof, N., Luis, R., Andrzej, R., Roland, E.S., Struijker, H.A.J. ,and Alberto Z. (2007). Guidelines for the management of Arterial Hypertension: The task force for the management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension, 25(6): 1105-1187.

13-Bastola .P., Pun .C.B.; Koirala S, and Shrestha U.K.(2012). Fasting serum lipids and fundus changes in hypertensive patients. Nepal Journal of Medical Sciences..1(2):103-7.

14-Saleem .,M.N.M.(2012). Determination of Some Biochemical Marker Levels in Serum of Patients with Congestive Heart Failure, Angina Pectoris and Myocardial Infarction .Eng & Tech Journal .30 (6): 939-949.

15-Erhardt L, Herlitz J, Bossaert L.(2002) .Task force on the management of chest pain . Eur. Heart J. 23 (15): 1153–76.

17-Ukoh, V.A. ,and Of orofuo, I.A. (2007). Plasma lipid profiles in Nigerians with normal blood pressure, hypertension and other acquired cardiac conditions. East Afr. Med. J. 84:264-70.

18-Akpa M.R., Agomouh D.I., and Alasia D.D. (2006). Lipid profile of healthy adult Nigerian in Port Harcourt, Nigeria. Niger. J. Med. 15:137-140.

19-Akuyam S. A., Aghogho U. B., Aliyu I. S and Bakari A. G.(2009). Serum total cholesterol in hypertensive Northern Nigerians. Int. J. of Med .Medical Sci .1.(3).73-78.

20-Pasupathi P, Rao Y.Y., and Farook J.(2009). Oxidative stress and cardiac biomarkers in patients with acute myocardial infarction. Euro. J. of Sci. Reas 27(2): 275-285.

21-Jeppesen, J.; Hein, H.O.; Suadicani, P., and Gyntelberg. F.(2000). Hightriglycerides and low HDL-Cholesterol and blood pressure and risk of ischemic heart disease .AM. Heart Association. 36: 226-232.

22-Smith S.C.; Jakson R., and Pearson T.A,. (2004). Principles for national and regional guidelines on cardiovascular disease prevention: A scientific statement from the world heart and stroke forum. Circulation . 109(25): 3112-3121.

23-Chatterjea M , and Shinde R ( 2005 ) Textbook of medical Biochemistry . 6th ed . J Aypee Brothers . Med . Pubi . LTD , New Delh : 1561-565

24-Singh U,and Jialal I.(2006). Oxidative stress and atherosclerosis. Pathophysiology . 13(3): 129-142. 25-Kumar, S.S., Anup, G., Baral, N., and Masky , R.(2011). Prevalence of Hypertension, Obesity, Diabetes, and Metabolic Syndrome in Nepal. nt J Hypertens.: 821971. 26-Kearney, P.M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P.K., and He, J. (2005). Global burden of hyper tension: Analysis of worldwide data. Lancet, 365(9455): 217-223.

27- De Fronzo R.A.(2010). Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture Diabetologia. ;53:1270–1287.

28-Williams S.B., Cusco J.A., and Roddy M.A. (1996). Impaired nitric oxide mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Am. Coll .Cardiol. 27:567–574 29-Qureshi. A.E.; Hameed. S.; and Nomen. A. (2013). Relationship of Serum Uric Acid Level and Angiographic Severity of Coronary Artery Disease in Male Patients with Acute Coronary Syndrome. Pak. J .Med. Sci. 29(5): 1137–1141

30-Diaz M, Frei B., Vita J.A., and Keaney J.(1997). Antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337(6): 408-416.

31-Anker, S.D.; Leyva, F. Pool-Wilson. P.A., Kox. W.J., and Stevenson, J.C. (1997). Relation between serum uric. acid and lower limb blood flow in patients with chromic heart failure .78(1):39-43.

32- Perlstein T.S., Gumieniak O., Williams G.H., Sparrow D., and Vokonas P.S (2006). Uric acid and the development of hypertension: the normative aging study. Hypertension 48: 1031-1036.

33-Teng F., Zhu R., Zou C., Xue Y., Yang M. (2011) Interaction between serum uric acid and triglycerides in relation to blood pressure. J. Human Hypertens. 25: 686-691.

34-Forman J.P.; Choi H. and Curhan G.C. (2007) Plasma uric acid level and risk for incident hypertension among men. J. Am. Soc .Nephrol. 18: 287-292.

35-Zhang W.; Sun. K.; Yang Y.; Zhang H.,and Hu F.B. (2009) Plasma uric acid and hypertension in a Chinese community: prospective study and metaanalysis. Clin Chem 55: 2026-2034.